Yuan-Sheng Zang1 article listing Yuan-Sheng Zang in Nature Communications, indexed by Paperzzz from Crossref and OSF.Anlotinib plus toripalimab as a first-line treatment in patients with advanced gastric cancer and performance status 2: the phase II APICAL-GC trial Nature Communications